logo

PNT(Delisted)

POINT BiopharmaยทNASDAQ
--
--(--)

PNT Profile

Point Biopharma Global Inc

A company that develops next-generation radioligand therapies for the treatment of cancer

--
09/18/2019
07/08/2020
NASDAQ Stock Exchange
129
12-31
Common stock
4850 West 78th Street, Indianapolis, IN, 46268
--
POINT Biopharma Global Inc was incorporated as a Delaware corporation on September 18, 2019. They are a late-stage clinical precision oncology company focused on the development and commercialization of next-generation radiopharmaceuticals for the treatment of cancer. Their goal is to make radiopharmaceuticals a treatment option for all cancer patients. They are advancing two Phase 3 assets in prostate cancer and neuroendocrine cancer as well as an early combination of next-generation product candidates.